Clinical Follow-up of Parkinson's Disease With Newly Prescribed Quetiapine

Mov Disord. 2020 Sep;35(9):1690-1692. doi: 10.1002/mds.28193. Epub 2020 Jul 29.

Daniel Weintraub^{1

2

3}, Claire Chiang⁴, Hyungjin Myra Kim^{4

5}, Jayne Wilkinson^{1

3}, Connie Marras⁶, Barbara Stanislawski⁴, Eugenia Mamikonyan³, Helen C Kales^{4

7

8}

¹ Parkinson's Disease Research, Education and Clinical Center (PADRECC), Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA.
² Mental Illness Research, Education and Clinical Center (MIRECC), Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA.
³ Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
⁴ Department of Veterans Affairs, HSR&D Center for Clinical Management Research (CCMR), Ann Arbor, Michigan, USA.
⁵ Consulting for Statistics, Computing & Analytics Research, University of Michigan, Ann Arbor, Michigan, USA.
⁶ Morton and Gloria Shulman Movement Disorder Centre, Toronto Western Hospital, University of Toronto and the Edmond J Safra Program in Parkinson's Disease, Tortonto, Ontario, Canada.
⁷ Geriatric Research, Education and Clinical Center (GRECC), VA Ann Arbor Healthcare System, Ann Arbor, Michigan, USA.
⁸ Department of Psychiatry, University of Michigan, Ann Arbor, Michigan, USA.

No abstract available

Publication types